What does XOMA Corp. do?

Jun 22 2025 06:15 PM IST
share
Share Via
XOMA Corp. is a micro-cap biotechnology company focused on developing monoclonal antibody-based therapeutics. As of March 2025, it reported net sales of $16 million and a net profit of $2 million.
Overview:
XOMA Corp. is a development-stage biotechnology company focused on the discovery and development of monoclonal antibody-based therapeutics, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company. Financial Snapshot: Most recent Net Sales: 16 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 2 Million (Quarterly Results - Mar 2025) Market-cap: USD 286.37 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 0.24 Return on Equity: -11.45% Price to Book: 3.38 Contact Details: Address: 2200 Powell St Ste 310, EMERYVILLE CA: 94608-1818 Tel: 1 510 2047239 Fax: 1 302 6555049 Website: https://www.xoma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News